William Aird: Rethinking Hemolysis Classification
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
“1/6
RETHINKING HEMOLYSIS CLASSIFICATION
I recently saw an incredibly rare but fascinating case of T-cell large granular lymphocytic (T-LGL)–mediated, DAT-negative hemolysis.
It prompted me to rethink how we classify hemolytic anemia and revise the schematic accordingly.
2/6
We usually divide hemolysis into immune and non-immune:
- Immune → antibody-mediated (autoimmune or alloimmune), DAT-positive
- Non-immune → mechanical, microangiopathic, infectious, toxic
That framework covers >99% of cases.
3/6
But what about the ultra-rare, cell-mediated form, when cytotoxic T or NK cells directly attack red cells or precursors?
- No antibodies.
- No complement.
- DAT-negative.
Mechanism: perforin/granzyme or Fas–FasL–mediated cytotoxicity.
4/6
These are not theoretical.
Occasional cases of LGL leukemia have shown evidence of direct, antibody-independent RBC destruction, essentially a cell-mediated immune hemolysis.
Vanishingly rare, but biologically fascinating.
5/6
So, I’ve updated the diagram.
Under “Immune hemolysis,” I’ve added a side branch:
“Cell-mediated (T/NK-cell cytotoxicity, DAT-negative)”
It’s a footnote in clinical reality but makes the schema more complete for those who enjoy a good hematologic deep dive.
6/6
If you teach or think about hemolysis, this nuance helps connect the adaptive (antibody-mediated) and cellular (cytotoxic) arms of immunity.
Sometimes the exceptions are what remind us how beautifully complex blood can be.”
Stay updated with Hemostasis Today.
-
Apr 6, 2026, 04:46Ursula Porage Dona: Bringing the Bleeding Disorders Community Together at WFH 2026 with NNHF
-
Apr 6, 2026, 04:17Arun V J: How War Reshaped Blood Transfusion
-
Apr 6, 2026, 03:57Isabella Cieri: How TEG Is Transforming Vascular Surgery Care
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia